Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

COSTEM 2023 | The importance of the EBMT/JACIE benchmarking program for HSCT outcomes

Riccardo Saccardi • 21 Oct 2023
COSTEM 2023

Riccardo Saccardi, MD, Careggi University Hospital, Florence, Italy, discusses the ongoing project by EBMT/JACIE that strives to develop an international risk-adapted benchmarking program for treatment centers to assess the quality of their hematopoietic stem cell transplantation (SCT) programs, and why this is necessary. This interview took place at The 8th Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM 2023), held in Berlin, Germany.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Riccardo Saccardi

2:13
Debating whether CAR-T cells are replacing autoSCT in the treatment of autoimmune diseases
Riccardo Saccardi • 21 Oct 2023
1:23
The impact of conditioning regimens on the outcomes of patients with autoimmune diseases
Riccardo Saccardi • 21 Oct 2023
1:28
Bettering transplant outcomes by optimizing stem cell mobilization
Riccardo Saccardi • 28 Mar 2017
1:50
Can transplant quality be improved by training medical personnel?
Riccardo Saccardi • 28 Mar 2017
The content of VJHemOnc is intended for healthcare professionals